Our annual conference is next week and we have a fantastic line up of over 70 speakers. This is why a record number of participants are now registered for the 4th annual Neurotech Conference in San Francisco next week. What do you have to gain?
- Find out about new product licensing and partnering opportunities
- Discover emerging technologies and companies
- Learn what venture and strategic investors are looking for
- Hear about cutting edge translational research and funding opportunities
- Meet and network with decision makers from across commercial neuroscience
Register Now - View Agenda with 70 Presenting Neurotech Executives
Join confirmed attendees who are now using the participant directory to network and set up one-on-one meetings: Aberdare Ventures, Accera, Accelemed, Adlyfe, Advanced Brain Monitoring, Alexza Pharmaceuticals, Alfred Mann Foundation, Alpha Omega, Alzheimer's Drug Discovery Foundation, Alzheimer's Research Forum and SWAN, ARCH Venture Partners, Arcion Therapeutics, Athena Technology Ventures, Autonomic Technologies, Avanir Pharmaceuticals, Avineuro Pharmaceuticals, Azevan Pharmaceuticals, Banyan Biomarkers, Bay City Capital, Bayhill Therapeutics, BCC Partners, Betterhumans, BioBehavioral Diagnostics, BioBusiness TV, BioCentury, Biotechnology Value Fund, BiotechPartnering Solutions, Boston Scientific Neuromodulation, Brain Resource, Brain Trust Accelerator Fund, BrainCells Inc., BrainScope Company, Brown Institute for Brain Science, Brown University, CCC Medical Devices, Center for BioEntrepreneurship UCSF, Ceregene, CHDI , Cloudera, Cognitive Drug Research, CollabRx, CoMentis, Conde Nast Portfolio Magazine, Corcept Therapeutics, CorTechs Labs Inc, Cortex Pharmaceuticals, Creative Commons, CureNeuro, Cyberonics, Cypress Bioscience, Cytox Group, D. E. Shaw Ventures, De Novo Ventures, Desitin Arzneimittel GMBH, DLA Piper, Electrical Geodesics, Eli Lilly and Company, Elminda , Elsevier Business Intelligence, Embera NeuroTherapeutics, Eos Neuroscience, Epilepsy Foundation, Epilepsy Therapy Project, EpiNano, Ernst Gallo Research Center, Ewing Marion Kauffman Foundation, Fast Forward, FasterCures, Feinstein Kean Healthcare, Flywheel Ventures, Genentech, Genesys Capital, Genzyme Corporation, George Greenstein Institute, Gladstone Institutes, Great Lakes BioSciences, HLM Venture Partners, Hoffmann-La Roche, Huntington's Disease Society of America, IDSC, LLC, Impax Pharmaceuticals, Inc. Magazine, iNetworks Advisors, Innovative NeuroTechnologies, Intellect Neurosciences, International Neuromodulation Society, Int'l Mental Health Research Organization, J. David Gladstone Institutes, Jan Medical, K&L Gates, Kansas Univ. Med. Center, Kappametrics Inc., Kinetics Foundation, Larta, Liverpool University, Lockheed Martin Aculight, Lou Ruvo Brain Institute, MDA Venture Philanthropy, MedAvante, MedStrategy, Medtronic, Medtronic Neuromodulation, Merck & Co, Merck Research Laboratories, Merz Pharmaceuticals GmbH, Methylation Sciences, Michael J. Fox Foundation, MicroTransponder, MIT Media Lab, Myelin Repair Foundation, Nabi Biopharmaceuticals, National Institutes of Health, Neostim, NeuroInsights, Neurologix, Neurolutions, Neuromodulation Ventures, Neuronascent, Neuronetics, Neuronetrix, NeuroNexus Technologies, NeuroNova AB, NeuroPace, Neurotechnology Industry Organization, Neurotech Reports, NeuroVentures, NFocus Neuromedical, NINDS/NIH, NIMH/NIH, North American Neuromodulation Society, Novartis Pharma AG, Novo Ventures, Omneuron, OpusGen, Otonomy, Oxford Bioscience Partners, Parexel, Pfizer, Pharmawire/Financial Times, Philips Research, Prexa Pharmaceuticals, Prize4Life, Prospect Venture Partners, Proteus Biomedical, PsychoGenics, PureTech Ventures, Q Therapeutics, QiG Group, San Jose BioCenter, Sanderling Ventures, Sandia National Laboratories, Satoris, Scale Venture Partners, Science Magazine, Science Futures, Siemens Venture Capital, Sierra Neuropharmaceuticals, Signum Biosciences, Silere Medical Technology, Shire, Sound Pharmaceuticals, SpectrumCare, Spinal Modulation, Spinal Muscular Atrophy Foundation, Stanford University, StemCells, Supernus Pharmaceuticals, Synsonix, Targacept, Technology Partners, Technology Review, Teva Pharmaceutical Industries, Texcel Medical, Thallo Bioscience Advisors, The Gray Sheet, The Jackson Laboratory, The Parkinson's Institute and Clinical Center, Thomas, McNerney & Partners, Transcept Pharmaceuticals, Tronics Medtech, UC Berkeley, Univ of Texas HSC/CCT, Univeristy of Pittsburgh Medical Center, University of California, Irvine, University of Utah, Versant Ventures, Vivo Ventures, Weill Cornell Medical College, World Brain Forum, Xytis Inc., Zarlink Semiconductor, Zoomedia
Reserve Your Spot Now and View Agenda. Don't miss this excellent networking opportunity to discover partnering opportunities from across commercial neuroscience.
Date: May 11-13, 2009
Location: St. Regis, San Francisco
Audience: CEOs, CSOs, CFOs, business development executives, non-profit leaders, corporate investors, venture capitalists, private equity investors, institutional investors, technology transfer experts, licensing executives